REG - Accrol Group Hldgs - Completion of Acquisition

Accrol groupAnnouncement

25/11/2020 07:01

RNS Number : 3909G
  
Accrol Group Holdings PLC
  
25 November 2020
  
 

25 November 2020
 
Accrol Group Holdings plc
("Accrol" or the "Company")
AIM: ACRL
 
Completion of the acquisition of Leicester Tissue Company Limited
 
Following the announcement made by the Company on the 23 November 2020 titled "Admission of Shares & Total Voting Rights" ("Announcement"), Accrol Group Holdings plc, a leading independent tissue converter in the UK, is pleased to announce that the Final Condition has now been satisfied and the Acquisition has now completed.
 
The capitalised terms used in this announcement have the same meanings as in the Announcement, unless otherwise stated.
 
Dan Wright, Executive Chairman of Accrol, said: 
 
"We are delighted to announce the completion of this, our first acquisition. LTC fulfils all our selective M&A criteria. It's well-invested; it's ideally located, in central England; it has strong day-to-day management team; and its product mix and customer base are highly complementary to our existing business. 
 
"The acquisition is immediately earnings enhancing and takes our share of the £1.7bn UK tissue market to c.16%. Importantly, it represents another milestone on our journey to build a world-class, operationally efficient business of size and scale, which delivers substantial returns to shareholders through organic and acquisitive growth. I would like to thank our existing and new shareholders for their support and confidence in our team and look forward to updating everyone on the progress of the integration in due course.
 
"On behalf of the team at Accrol, I welcome everyone at LTC to the Group and look forward to an exciting future working together."        
 



For further information, please contact:


















Accrol Group Holdings plc








Dan Wright, Executive Chairman


Via Belvedere Communications




Gareth Jenkins, Chief Executive Officer


















Zeus Capital Limited (Nominated Adviser & Broker) 








Dan Bate / Jordan Warburton


Tel: +44 (0) 161 831 1512




Dominic King / John Goold 


Tel: +44 (0) 203 829 5000














Liberum Capital Limited (Joint Broker)


Tel: +44 (0) 20 3100 2222




Clayton Bush / Edward Thomas


















Deloitte LLP (Financial Adviser)


Tel: +44 (0) 20 7936 3000




Andrew Westbrook / Chris Nicholls


















Belvedere Communications Limited








Cat Valentine


Tel: +44 (0) 7715 769 078




Keeley Clarke 


Tel: +44 (0) 7967 816 525




Llew Angus


Tel:  +44 (0) 7407 023 147








accrolpr@belvederepr.com



 
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. The business operates from four sites in Lancashire:
 



·


A manufacturing, storage, and distribution facility in Blackburn;




·


A storage and administrative centre in Blackburn;




·


A facial tissue plant, also in Blackburn; and




·


A manufacturing, storage, and distribution facility in Leyland.



 
For more information, please visit www.accrol.com. 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ACQFEAFALESSEDF